Page last updated: 2024-10-21

phenytoin and Crohn Disease

phenytoin has been researched along with Crohn Disease in 1 studies

Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.

Research Excerpts

ExcerptRelevanceReference
"A patient with Crohn's disease and generalized seizures who lacked the distal small bowel and ascending colon required 600 mg of intravenous phenytoin daily (11 mg/kg/24 h) to maintain her plasma phenytoin levels in the 12-24 micrograms/ml range."1.27Enhanced gastrointestinal excretion of phenytoin in a patient with Crohn's disease. ( Gardner, M; Irace, P; Kutt, H; Lesser, RP; Pippenger, CE; Terrentine, S; Winkelman, EL, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lesser, RP1
Irace, P1
Kutt, H1
Pippenger, CE1
Winkelman, EL1
Terrentine, S1
Gardner, M1

Other Studies

1 other study available for phenytoin and Crohn Disease

ArticleYear
Enhanced gastrointestinal excretion of phenytoin in a patient with Crohn's disease.
    Epilepsia, 1984, Volume: 25, Issue:3

    Topics: Adult; Crohn Disease; Female; Humans; Injections, Intravenous; Intestinal Absorption; Phenytoin

1984